Direct Electrochemistry of Cytochrome P450 Reductases in Surfactant and Polyion Films

NADPH‐cytochrome P450 reductase (CPR) serves as electron donor for cytochrome P450 catalyzed monooxygenase reactions utilizing flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) as electron transfer cofactors. Here, stable films of human and rabbit CPRs with didodecyldimethylammonium bromide (DDAB), dimyristoylphosphatidyl choline (DMPC), and poly(diallyldimethylammonium) (PDDA) were made on pyrolytic graphite (PG) electrodes for comparative structural and electrochemical studies. CD and UV‐VIS absorbance spectra suggested that near native CPR conformation is retained in PDDA films, and some conformational changes occur in DMPC or DDAB films. Cyclic voltammetry of these films gave quasireversible pairs of peaks at average formal potential ?0.246±0.008 V vs. NHE. In human CPR‐DDAB (H‐CPR‐DDAB), a second pair of peaks at +0.317 V vs. NHE was found that depended strongly on identity of buffer and salt. Excepting H‐CPR in DDAB, films showed similar voltammetry, formal potentials, and k_s values. While CPR‐PDDA films had near native CPR structures, electrochemical parameters did not differ significantly from CPR‐DMPC films. The relative independence of film voltammetry from the influence of film materials for CPRs is in contrast with heme iron proteins that, while retaining near native structures, have formal potentials that depend significantly on identity of the film material.     

Preparation,characterization, and binding profile of imprinted semi-IPN cryogel composite for aluminum

Human body is greatly exposed to aluminum due to its high abundance in the environment. This nonessential metal is a threat to the patients of chronic renal disorders, as it is easily retained in their plasma and quickly accumulates in different tissues. Thus, there is great need to remove it from the aqueous environment. In this study, Al³⁺ imprinted semiinterpenetrating polymer network (semi-IPN)-based cryogel composite was prepared and applied for the purification of environmental and drinking water samples from aluminum. Poly (2-hydroxyethyl methacrylate) (pHEMA) discs were produced via cryogenic treatment and imprinted semi-IPN was introduced to the 3-(trimethoxysilyl) propyl acrylatemodified macroporous cryogel discs. The adsorption properties and selectivity of the aluminum (III) imprinted semi-IPN cryogel composite were studied in detail. The imprinted semi-IPN cryogel composite showed good selectivity towards aluminum (III) ions with the imprinting factor (IF) of 76.4 in the presence of competing copper (II), nickle (II), and iron (III) ions. The maximum adsorption capacity of 271 μmol g^-1 was obtained for aluminum (III) at pH 7.0 within 10 min using imprinted semi-IPN cryogel composite. The good selectivity and reusability of aluminum (III)-imprinted semi-IPN cryogel composite makes this material an eligible candidate for the purification of drinking water from aluminum (III) leaving important minerals remained in the water.     

Synthesis and Characterization of High-Quality Polycrystalline Sample NiV2O6 by Solid-State Reaction Technique

Physics of the Solid State - Employing the solid-state reaction route, good quality polycrystalline sample NiV2O6 is prepared that has effective application in rechargeable Li-ion batteries. The...     

Ru (III) Schiff‐base complex anchored on nanosilica as an efficient and retrievable catalyst for hydration of nitriles

Transition metal catalyzed hydration of nitriles is an attractive methodology for amide synthesis, and hence recently attracted wide attention. It is one of the significant organic transformations as amides play a vital role in biological, pharmaceutical and industrial applications. In this work, we report the synthesis of a new solid supported Ru (III) Schiff base complex, Ru@imine‐nanoSiO₂ immobilized on nanosilica obtained from rice husk. The complex was characterized by FTIR, powder X‐ray diffraction, BET surface area measurement, UV–vis, SEM–EDX, TEM, ESR, X‐ray photoelectron spectroscopy and ICP‐AES analysis. Using Ru@imine‐nanoSiO₂ as the catalyst, the hydration of nitriles in i‐PrOH at 40 °C was studied which resulted in good isolated yields (60–99%). The catalyst can be recycled and reused up to 5^th cycle without any loss in activity. The products were characterized by FTIR, GC–MS and ¹H‐NMR spectroscopy and compared with authentic samples.     

Validated Method for the Simultaneous Determination of Gemifloxacin and H2‐receptor Antagonists in Bulk,Pharmaceutical Formulations and Human Serum by RP‐HPLC; In‐vitro Applications

Simple, isocratic and rapid RP‐HPLC method has been developed for the simultaneous analysis of gemifloxacin and H₂‐receptor antagonists i.e. Cimetidine, Famotidine and Ranitidine, in bulk, pharmaceutical formulation and human serum. Separation was achieved on the RP‐Mediterranea column [C18 (250 × 4.6 mm, 5 μ)] at ambient temperature using mobile phase consisting of acetonitrile: methanol: water (20:28:52 v/v/v pH 2.8 adjusted by phosphoric acid). Flow rate was 1.0 mL/min with an average operating pressure of 180 kg/cm². Gatifloxacin (GATI) was used as an internal standard (IS). Quantitation was achieved with UV detection at 221, 256 and 267 nm, respectively. Linear calibration curves, at concentration ranges of 0.05‐37.5 μgmL^‐L with a correlation coefficient of ±0.9994. The detection and quantification limits were in the ranges of 0.023‐0.250 μgmL^‐L and 0.071‐0.756 μgmL^‐L, respectively. Friedman's and Student's t‐test were applied to correlate these results. Method was validated in terms of selectivity, linearity, precision, robustness, recovery, limits of detection and quantitation and is applicable to the routine analysis of GFX and H₂‐receptor antagonists, alone or in combination.     

Development and Validation of a Liquid Chromatographic Method for the Determination of Leflunomide: Application to in vitro Drug Metal Interactions

Leflunomide is a leading drug for the treatment of rheumatoid arthritis. The principle aim of this study was to develop and validate an RP‐HPLC method for the determination of leflunomide in bulk and pharmaceutical dosage form using diclofenac sodium as an internal standard. For this purpose, chromatography was accomplished on a Purospher Start, C₁₈ (5 (m, 12.5 cm×0.46 cm) column at ambient temperature. Methanol:water (80:20, V/V) solvent system was selected as mobile phase, the pH of which was adjusted to 3.4 by ortho‐phosphoric acid and delivered at a flow rate of 1.2 mL·min⁻¹. Seperation of leflunomide and diclofenac sodium was carried out on a Purospher Start, C₁₈ equipped with a UV‐visible detector at 248 nm. The suitability of the method for the quantitative determination of the drugs is proven by validation in accordance with the requirements laid down by the International Conference on Harmonization (ICH) guidelines. The method was accurate (99.55%–100.03%), specific, linear (R²>0.999) and precise (intra‐day precision 0.023%–0.93% and inter‐day precision 0.26%–0.944%) in the range of 0.5–20 (g·mL⁻¹. The minimum limit of detection and quantification in pharmaceutical formulation were 0.05 and 0.15 (g·mL⁻¹, respectively. Thus the proposed method is simple, accurate, reproducible and suitable for the routine analysis of leflunomide in pharmaceutical formulations and was applied to study in vitro drug‐metal interactions.     

Determination of Alendronate Sodium by Box-Behnken Statistical Design

Spectrophotometric and LC methods have been developed and validated for the analysis of alendronate sodium in tablet dosage forms. Methods were based on reaction of the primary amino group of alendronate with ninhydrin reagent in methanolic solution of sodium bicarbonate. The condensed product exhibited UV absorption maximum at 569 nm whereas neither the reagents nor the analyte had any UV absorption. A Box-Behnken statistical design was employed to study the effect of independent variables, ninhydrin (X ₁ ), NaHCO₃ (X ₂ ) and drug concentration (X ₃ ) on dependent variable, absorption via spectrophotometer. From the point prediction tool of design software, it was observed that ninhydrin (0.26%) and NaHCO₃ (0.048 mol L^?1) produced maximum absorption. These optimized parameters were then selected for method validation. The methods obeyed Beer’s law over a selected concentration range with good correlation co-efficient (>0.99). The limit of detection and limit of quantification were 4.5 and 13.75 μg mL^?1 by spectroscopy, and 87 and 263 ng mL^?1 by LC, respectively. Accuracy, precision and % recovery were satisfactory for the proposed method. The method was highly feasible and reproducible for determination of alendronate sodium in bulk powder and pharmaceutical dosage form.     

Simultaneous Determination of Paracetamol and Orphenadrine Citrate in Dosage Formulations and in Human Serum by RP‐HPLC

Rapid liquid chromatographic procedures are proposed for analysis of paracetamol and orphenadrine citrate in pharmaceutical preparations and human serum using acetonitrile: water (50:50) as a mobile phase, adjusting pH to 2.6, UV detection at 215 nm and propylparaben sodium as internal standard. The advantages of this method include good and rapid separation, well resolved peaks, and only a small amount of sample is required for assay and adequate precision. The method showed good linearity in the range of 6 to 10000 ng/mL for paracetamol serum concentrations with a correlation coefficient 0.9999 (inter and intra day CV < 3.15) and in the range 3–10000 ng/mL for orphenadrine citrate serum concentrations with a correlation coefficient of 0.9999 (inter and intra day CV < 3.58). The recovery of paracetamol and orphenadrine citrate was > 96.9% and > 96.7%, respectively. The proposed method may be used for the quantitative analysis of paracetamol and orphenadrine citrate alone or in combination from raw materials, in bulk drugs, dosage formulations and in serum.     

High-performance Liquid Chromatographic Analysis of Pioglitazone,Gliquidone,Rosuvastatin and Simvastatin in Formulations and Human Serum

Co‐administration of HMG‐CoA reductase with antidiabetic drugs is most common since antidiabetic drugs are mostly prescribed for long term therapy. In the present paper, we describe the simultaneous determination of antidiabetic (pioglitazone hydrochloride and gliquidone) in presence of statins (rosvastatin and simvastatin) in formulations and in human serum using RP‐HPLC technique. The serum samples were subjected to protein precipitation with acetonitrile prior to an HPLC analysis. At a flow rate of 1 mL·min⁻¹ isocratic elution was employed, using mobile phase consisting of methanol/water (90:10, V:V), pH 3.50 with phosphoric acid and absorbance was recorded at 235 nm. The assay was reproducible, linear (concentration range of 5–50 μg·mL⁻¹) and accurate. The LOD and LOQ values were 1.32, 0.28, 0.05 and 0.57 μg·mL⁻¹ and 4.39, 0.93, 0.16 and 1.90 μg·mL⁻¹ for pioglitazone hydrochloride, gliquidone, rosvastatin and simvastatin, respectively. There were no interfering peaks due to the excipients present in the pharmaceutical tablet and serum. Thus, the proposed method is simple and suitable for the analysis of active ingredient in tablet form and human serum.     

Metal ion-catalysed reduction of indolic imides,a facile β-carboline synthesis

A novel procedure for the synthesis of β-carbolines by metal catalysed reduction of imides with sodium borohydride is described.